These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 17675928)

  • 1. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease.
    Arnáiz E; Almkvist O
    Acta Neurol Scand Suppl; 2003; 179():34-41. PubMed ID: 12603249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
    Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
    Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
    Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
    Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment in different functional domains and incident Alzheimer's disease.
    Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Bennett DA
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1479-84. PubMed ID: 16227534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropsychological aspects of Alzheimer's disease].
    Traykov L; Marcie P; Dalla Barba G; Boller F
    Rev Neurol (Paris); 1999; 155 Suppl 4():S38-43. PubMed ID: 10637937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
    Dickerson BC; Sperling RA; Hyman BT; Albert MS; Blacker D
    Arch Gen Psychiatry; 2007 Dec; 64(12):1443-50. PubMed ID: 18056553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
    Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
    Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
    J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological predictors of everyday memory and everyday functioning in patients with mild Alzheimer's disease.
    Cahn-Weiner DA; Ready RE; Malloy PF
    J Geriatr Psychiatry Neurol; 2003 Jun; 16(2):84-9. PubMed ID: 12801157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease.
    Ivanoiu A; Adam S; Van der Linden M; Salmon E; Juillerat AC; Mulligan R; Seron X
    J Neurol; 2005 Jan; 252(1):47-55. PubMed ID: 15654553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Awareness of deficits and anosognosia in Alzheimer's disease].
    Antoine C; Antoine P; Guermonprez P; Frigard B
    Encephale; 2004; 30(6):570-7. PubMed ID: 15738860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation.
    Irish M; Lawlor BA; Coen RF; O'Mara SM
    BMC Neurosci; 2011 Aug; 12():80. PubMed ID: 21816065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease.
    Palmer K; Bäckman L; Winblad B; Fratiglioni L
    Int Psychogeriatr; 2008 Apr; 20(2):252-8. PubMed ID: 18257960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive functions deficit in mild cognitive impairment.
    Traykov L; Raoux N; Latour F; Gallo L; Hanon O; Baudic S; Bayle C; Wenisch E; Remy P; Rigaud AS
    Cogn Behav Neurol; 2007 Dec; 20(4):219-24. PubMed ID: 18091070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition.
    Nordlund A; Rolstad S; Hellström P; Sjögren M; Hansen S; Wallin A
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1485-90. PubMed ID: 16227535
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.